The AJT report: News and issues that affect organ and tissue transplantation

American Journal of Transplantation

Volumn 10, Issue 1, 2010, Pages 2-4

  Pondrom, Sue ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; ECULIZUMAB; IMMUNOGLOBULIN; PANEL REACTIVE ANTIBODY; RITUXIMAB;

ACUTE GRAFT REJECTION; ANEMIA; ANOREXIA; ARGENTINA; ASTHENIA; AUSTRALIA; CANCER PATIENT; CHRONIC GRAFT REJECTION; CLINICAL PRACTICE; CLINICAL TRIAL; CONSTIPATION; DECREASED APPETITE; DIARRHEA; DRUG MEGADOSE; DRUG SAFETY; FEVER; HIGH RISK PATIENT; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLUENZA VIRUS A H1N1; LEUKOPENIA; LOW DRUG DOSE; MEDICAL PERSONNEL; MENTAL DISEASE; MULTIPLE MYELOMA; NEURALGIA; NEUROPATHY; NEUTROPENIA; NOTE; ORGAN TRANSPLANTATION; PERIPHERAL NEUROPATHY; PHYSICIAN; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEASONAL VARIATION; THROMBOCYTOPENIA; TISSUE TRANSPLANTATION; VOMITING;

ANTIBODIES, MONOCLONAL; BORONIC ACIDS; DESENSITIZATION, IMMUNOLOGIC; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; PLASMAPHERESIS; PYRAZINES; TRANSPLANTATION IMMUNOLOGY;

EID: 72549113965     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02978.x     Document Type: Note

References (10)

1. Stegall MD, Gloor J, Winters JL, Moore SB, DeGoey S. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006 6 (2 346 351.
2. Zachary AA, Kopchaliiska D, Montgomery RA, Leffell MS. HLA-specific B cells: I. A method for their detection, quantification, and isolation using HLA tetramers. Transplantation 2007 83 (7) 982 988 and 989 994
3. Jordan SC, Tyan D, Stablein D, et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 2004 15 (12 3256 3262.
4. Vo AA, Lukovsky M, Toyodo M, et al. Rituximab and intravenous immunoglobulin for desensitization during renal transplantation. N Engl J Med 2008 359 (3 242 251.
5. Vo AA, Caao K, Lai CH, et al. Long term outcomes in highly-HLA sensitized patients receiving desensitization with IVIG and single-dose rituximab. [2009 ATC abstract 1312]. Am J Transplant 2009 9 (s2 557.
6. Everly MJ, Everly JJ, Susskind B, et al. Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation 2008 86 (12 1754 1761.
7. Everly MJ, Trivedi HL, Terasaki PI, et al. Optimizing bortezomib to remove donor specific HLA antibodies prior to allograft dysfunction. [2009 ATC abstract LB05]. Am J Transplant 2009 9 (s2 383.
8. Stegall MD, Diwan TS, Burns JM. Prevention of acute humoral rejection with C5 inhibition. [2009 ATC abstract 178]. Am J Transplant 2009 9 (s2 241 242.
9. OPTN/UNOS Guidance Regarding H1N1 and implications for transplantation [press release]. Richmond, VA : UNOS October 2, 2009.
10. White DB, Angus DC. Preparing for the sickest patients with 2009 influenza A(H1N1). JAMA 2009 Oct 12 [Epub ahead of print].